SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-04-006415
Filing Date
2004-05-14
Accepted
2004-05-14 15:10:57
Documents
5
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y97534e10vq.txt 10-Q 119198
2 CERTIFICATION y97534exv31w1.txt EX-31.1 3410
3 CERTIFICATION y97534exv31w2.txt EX-31.2 3419
4 CERTIFICATION y97534exv32w1.txt EX-32.1 1385
5 CERTIFICATION y97534exv32w2.txt EX-32.2 1407
  Complete submission text file 0000950123-04-006415.txt   130918
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 04806976
SIC: 2835 In Vitro & In Vivo Diagnostic Substances